United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win [Seeking Alpha]
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $600.00 to $660.00. They now have a "buy" rating on the stock.
United Therapeutics (UTHR) had its price target raised by Wells Fargo & Company from $486.00 to $575.00. They now have an "equal weight" rating on the stock.
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo [Yahoo! Finance]
United Therapeutics (UTHR) had its price target raised by Bank of America Corporation from $569.00 to $626.00. They now have a "neutral" rating on the stock.